Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v3.8.0.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
EXPENSES        
Research and development $ 825 $ 69 $ 948 $ 206
General and administrative 1,550 329 1,902 899
Total operating expenses 2,375 398 2,850 1,105
OTHER INCOME (EXPENSE)        
Interest income 9   9  
Bargain purchase gain [note 2] 1,272   1,272  
Contingent value rights recovery [note 2] 200   200  
Gain on warrants 111   111  
Loss on disposition of intangible asset [note 4] (8,610)   (8,610)  
Other expenses (7) (7) (26) (20)
Total other income (expense) (7,025) (7) (7,044) (20)
Net loss before income taxes (9,400) (405) (9,894) (1,125)
Recovery of deferred income taxes [note 4] 2,928 137 3,051 377
Net loss (6,472) (268) (6,843) (748)
OTHER COMPREHENSIVE INCOME        
Comprehensive loss $ (6,472) $ (268) $ (6,843) $ (748)
Basic and diluted net loss per common share $ (0.90) $ (12.62) $ (2.81) $ (35.23)
Shares used in computation of basic and diluted net loss per common share 7,225,826 21,230 2,435,095 21,230